Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Brigade Capital and Kindred Healthcare Inc (KND)

Kindred Healthcare Inc (NYSE:KND): Don Morgan’s Brigade Capital filed an amended 13D.

You can check out Brigade Capital’s latest holdings and filings here.

Please follow Brigade Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Brigade Capital or update its stock holdings.

Don Morgan
Don Morgan
Brigade Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Brigade Capital Management 0 6,891,602 0 6,891,602 6,891,602 7.54%
Brigade Capital Management GP 0 6,891,602 0 6,891,602 6,891,602 7.54%
Brigade Leveraged Capital Structures Fund Ltd. ( 0 5,884,031 0 5,884,031 5,884,031 6.44%
Brigade Distressed Value Master Fund Ltd. ( 0 922,571 0 922,571 922,571 1.01%
Tasman Fund 0 0 0 0 0 0.0%
Brigade Cavalry Fund Ltd. ( 0 85,000 0 85,000 85,000 0.09%
Donald E. Morgan, III 0 6,891,602 0 6,891,602 6,891,602 7.54%
Don Morgan
Don Morgan
Brigade Capital

Page 1 of 15 – SEC Filing



Washington, D.C. 20549 


Under the Securities Exchange Act
of 1934

(Amendment No. 4)* 


(Name of Issuer)

Common Stock, $0.25 par value per share

(Title of Class of Securities)



(CUSIP Number)


Aaron Michael Daniels, Esq.

Brigade Capital Management, LP

399 Park Ave, 16th Floor

New York, NY 10022

(212) 745-9700

with a copy to:

Steven E. Siesser, Esq.

Lawrence M. Rolnick, Esq.

Lowenstein Sandler LLP

1251 Avenue of the Americas, 17th Floor

New York, New York 10020

(212) 204-8688


(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

March 23, 2018

(Date of Event which Requires Filing of this

If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and
is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Kindred Healthcare Inc (NYSE:KND)
Trade (NYSE:KND) Now!